POS-300 Patient-reported early stage chronic kidney disease

Affiliations

A. ABDUL SULTAN: AstraZeneca, Global Medical BioPharmaceutical- BioPharmaceuticals, Cambridge, United Kingdom
E. Wittbrodt: Astrazeneca, Global Medical BioPharmaceutical- BioPharmaceuticals, Gaithersburg, United States
E. Malvolti: AstraZeneca, Global Medical BioPharmaceutical- BioPharmaceuticals, Cambridge, United Kingdom
J. Guzek: HealthLumen Limited, Mathematical Modelling Department, London, United Kingdom
L. Webber: HealthLumen Limited, Mathematical Modelling Department, London, United Kingdom
L. Retat: HealthLumen Limited, Mathematical Modelling Department, London, United Kingdom
J.J. Garcia Sanchez: Astrazeneca, Global Market Access & Pricing BioPharmaceuticals, Cambridge, United Kingdom
C. Hungta: Astrazeneca, Biometerics- R&D BioPharmaceuticals, Gaithersburg, United States
S. Barone: Astrazeneca, Global Medical BioPharmaceutical- BioPharmaceuticals, Gaithersburg, United States

Abstract

No abstracts available.

ISSN: 2468-0249 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
Website: http://www.journals.elsevier.com/kidney-international-reports/